genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Eye Disorders

      Prime Editing Reverses Vision Loss in Mice

      3D illustration Rendering of binary code pattern.Futuristic Particles digital Landscape wave Abstract background for business,Science and technology
      Artificial Intelligence

      AI-Proofing Workflows in Drug Development

      Lung Cancer
      Cancer

      New Drug Combo Reduces Lung Tumors in Mice

      Corn crop
      AgBio

      Gene Discovery May Help Effort to Breed Climate Resilient Crops

      RNA strands consisting of nucleotides important for protein bio-synthesis
      Cancer

      Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Abstract Colorful Blue Radial Glitch Chromatic Holographic Background
      Cancer

      Lightspeed’s Jonathan MacQuitty and the Laws of Biotech Relativity

      scientists workin
      Biologics

      Biologics Manufacturing without the Cells

      Bioprocessing

      Bio-Inspired Coatings Could Make Cell Activation More Efficient in Therapy Production

      Bioprocessing

      Vortex-Focusing Microfluidics Yields Precisely Sized Liposomes at Scale

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home Neurological Disorders ALS

ALS

  • ALS
  • Alzheimers
  • Mental Health Disorders
  • Parkinsons
  • Schizophrenia
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Alzheimer Neurons
    ALS

    Innate Immune Molecule Implicated in ALS Neurodegeneration

    ALS

    Stress Test: ProJenX’s Oral Drug Shows Early Promise vs. ALS

    Neurological Disorders

    Neumora Completes $112M Series B to Develop Precision Neuro Therapies

    Neuron system
    ALS

    StockWatch: Despite Approval in ALS, Amylyx Sees No Price Surge

    Nanotechnology

    Clene Energy: Nanocrystal Developer Pursues Remyelination vs. MS, ALS

    Degradation of motor neurons, illustration
    ALS

    Longer-Term Use of Investigational Drug Stabilizes ALS Symptoms

    ALS

    Repurposed Drug Shows Preclinical Promise against Amyotrophic Lateral Sclerosis

    Neuron system
    ALS

    StockWatch: Investors Warm to Amylyx as FDA Panel Revisits ALS Drug

    Financing

    StockWatch: Layoffs Fail to Lift Novartis

    ALS

    Triple Threat: NeuroSense Targets ALS

    Neurological Disorders

    StockWatch: Praxis Shares Crater 75% as Aria Strikes a Sour Note

    Neurological Disorders

    StockWatch: ALS Setback Hammers Amylyx, Longeveron Doubles on Positive Alzheimer’s Data

    ALS

    ALS-Linked TDP-43 Aggregates Seen Clearly Enough to Raise Treatment Hopes

    ALS

    Steering Stem Cells to Repair Sites Using Inflammo-Free Inflammo-Attraction

    Lab mouse
    Sponsored

    Working with ALS Mice: Guidelines for Preclinical Testing and Colony Management

    1234Page 1 of 4

    Recently Featured

    Prime Editing Reverses Vision Loss in Mice

    Prime Editing Reverses Vision Loss in Mice

    AI-Proofing Workflows in Drug Development

    AI-Proofing Workflows in Drug Development

    Gene Discovery May Help Effort to Breed Climate Resilient Crops

    Gene Discovery May Help Effort to Breed Climate Resilient Crops

    Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

    Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up